Listed

ArriVent BioPharma, Inc.

AVBPNasdaqCIK 1868279HealthcareFiscal year ends Dec 31

Share

Share this page

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Operating income−$52.7m, Q2 FY2026
Net income−$49.9m, Q2 FY2026
Line itemUnitperiod not labelled2023-09-30period not labelled2023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Research and development$m14.3Research and development, period not labelled, three months to 2023-09-30$14.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-14, accession 0001558370-24-015624.Report this figure20.0Research and development, period not labelled, three months to 2023-12-31$20.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-03, accession 0001558370-25-001999. Derived: 12-month figure less the 9-month figure.Report this figure17.0Research and development, Q1 FY2024, three months to 2024-03-31$17.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-12, accession 0001558370-25-007276.Report this figure21.8Research and development, Q2 FY2024, three months to 2024-06-30$21.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-11, accession 0001558370-25-010975.Report this figure20.1Research and development, Q3 FY2024, three months to 2024-09-30$20.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-10, accession 0001104659-25-108847.Report this figure20.2Research and development, Q4 FY2024, three months to 2024-12-31$20.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-05, accession 0001104659-26-024127. Derived: 12-month figure less the 9-month figure.Report this figure61.3Research and development, Q1 FY2025, three months to 2025-03-31$61.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-11, accession 0001104659-26-058650.Report this figure27.7Research and development, Q2 FY2025, three months to 2025-06-30$27.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-12, accession 0001104659-26-094902.Report this figure32.2Research and development, Q3 FY2025, three months to 2025-09-30$32.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-10, accession 0001104659-25-108847.Report this figure32.2Research and development, Q4 FY2025, three months to 2025-12-31$32.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-05, accession 0001104659-26-024127. Derived: 12-month figure less the 9-month figure.Report this figure37.6Research and development, Q1 FY2026, three months to 2026-03-31$37.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-11, accession 0001104659-26-058650.Report this figure42.3Research and development, Q2 FY2026, three months to 2026-06-30$42.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-12, accession 0001104659-26-094902.Report this figure
Operating income$m(16.7)Operating income, period not labelled, three months to 2023-09-30−$16.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-14, accession 0001558370-24-015624.Report this figure(23.1)Operating income, period not labelled, three months to 2023-12-31−$23.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-03, accession 0001558370-25-001999. Derived: 12-month figure less the 9-month figure.Report this figure(20.7)Operating income, Q1 FY2024, three months to 2024-03-31−$20.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-12, accession 0001558370-25-007276.Report this figure(25.7)Operating income, Q2 FY2024, three months to 2024-06-30−$25.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-11, accession 0001558370-25-010975.Report this figure(24.2)Operating income, Q3 FY2024, three months to 2024-09-30−$24.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-10, accession 0001104659-25-108847.Report this figure(23.7)Operating income, Q4 FY2024, three months to 2024-12-31−$23.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-05, accession 0001104659-26-024127. Derived: 12-month figure less the 9-month figure.Report this figure(66.8)Operating income, Q1 FY2025, three months to 2025-03-31−$66.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-11, accession 0001104659-26-058650.Report this figure(33.6)Operating income, Q2 FY2025, three months to 2025-06-30−$33.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-12, accession 0001104659-26-094902.Report this figure(38.3)Operating income, Q3 FY2025, three months to 2025-09-30−$38.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-10, accession 0001104659-25-108847.Report this figure(38.8)Operating income, Q4 FY2025, three months to 2025-12-31−$38.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-05, accession 0001104659-26-024127. Derived: 12-month figure less the 9-month figure.Report this figure(46.1)Operating income, Q1 FY2026, three months to 2026-03-31−$46.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-11, accession 0001104659-26-058650.Report this figure(52.7)Operating income, Q2 FY2026, three months to 2026-06-30−$52.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-12, accession 0001104659-26-094902.Report this figure
Net income$m(14.4)Net income, period not labelled, three months to 2023-09-30−$14.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-14, accession 0001558370-24-015624.Report this figure(21.2)Net income, period not labelled, three months to 2023-12-31−$21.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-03, accession 0001558370-25-001999. Derived: 12-month figure less the 9-month figure.Report this figure(17.4)Net income, Q1 FY2024, three months to 2024-03-31−$17.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-10, accession 0001104659-25-108847.Report this figure(21.9)Net income, Q2 FY2024, three months to 2024-06-30−$21.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-10, accession 0001104659-25-108847.Report this figure(20.6)Net income, Q3 FY2024, three months to 2024-09-30−$20.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-10, accession 0001104659-25-108847.Report this figure(20.6)Net income, Q4 FY2024, three months to 2024-12-31−$20.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-05, accession 0001104659-26-024127. Derived: 12-month figure less the 9-month figure.Report this figure(64.4)Net income, Q1 FY2025, three months to 2025-03-31−$64.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-12, accession 0001104659-26-094902.Report this figure(31.4)Net income, Q2 FY2025, three months to 2025-06-30−$31.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-12, accession 0001104659-26-094902.Report this figure(35.0)Net income, Q3 FY2025, three months to 2025-09-30−$35.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-10, accession 0001104659-25-108847.Report this figure(35.5)Net income, Q4 FY2025, three months to 2025-12-31−$35.5m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-05, accession 0001104659-26-024127. Derived: 12-month figure less the 9-month figure.Report this figure(43.3)Net income, Q1 FY2026, three months to 2026-03-31−$43.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-12, accession 0001104659-26-094902.Report this figure(49.9)Net income, Q2 FY2026, three months to 2026-06-30−$49.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-12, accession 0001104659-26-094902.Report this figure
Diluted EPS$ per share(5.52)Diluted EPS, period not labelled, three months to 2023-09-30−$5.52 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-14, accession 0001558370-24-015624.Report this figurenot reported(0.70)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.70 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-12, accession 0001558370-25-007276.Report this figure(0.65)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.65 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-11, accession 0001558370-25-010975.Report this figure(0.61)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.61 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-10, accession 0001104659-25-108847.Report this figurenot reported(1.90)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$1.90 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-11, accession 0001104659-26-058650.Report this figure(0.90)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.90 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-12, accession 0001104659-26-094902.Report this figure(0.83)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.83 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-10, accession 0001104659-25-108847.Report this figurenot reported(0.96)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.96 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-11, accession 0001104659-26-058650.Report this figure(1.05)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$1.05 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-12, accession 0001104659-26-094902.Report this figure
Basic EPS$ per share(5.52)Basic EPS, period not labelled, three months to 2023-09-30−$5.52 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-14, accession 0001558370-24-015624.Report this figurenot reported(0.70)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.70 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-12, accession 0001558370-25-007276.Report this figure(0.65)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.65 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-11, accession 0001558370-25-010975.Report this figure(0.61)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.61 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-10, accession 0001104659-25-108847.Report this figurenot reported(1.90)Basic EPS, Q1 FY2025, three months to 2025-03-31−$1.90 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-11, accession 0001104659-26-058650.Report this figure(0.90)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.90 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-12, accession 0001104659-26-094902.Report this figure(0.83)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.83 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-10, accession 0001104659-25-108847.Report this figurenot reported(0.96)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.96 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-11, accession 0001104659-26-058650.Report this figure(1.05)Basic EPS, Q2 FY2026, three months to 2026-06-30−$1.05 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-12, accession 0001104659-26-094902.Report this figure

Balance sheet

Cash and equivalents$154.7m, Q2 FY2026
Shareholders' equity$366.8m, Q2 FY2026
Line itemUnitperiod not labelled2023-09-30period not labelled2023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$mnot reported150Cash and equivalents, period not labelled, at 2023-12-31$150.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-03, accession 0001558370-25-001999.Report this figure317Cash and equivalents, Q1 FY2024, at 2024-03-31$317.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-08, accession 0001558370-24-007197.Report this figure299Cash and equivalents, Q2 FY2024, at 2024-06-30$298.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-14, accession 0001558370-24-012236.Report this figure283Cash and equivalents, Q3 FY2024, at 2024-09-30$282.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-14, accession 0001558370-24-015624.Report this figure74.3Cash and equivalents, FY2024, at 2024-12-31$74.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-05, accession 0001104659-26-024127.Report this figure49.9Cash and equivalents, Q1 FY2025, at 2025-03-31$49.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-12, accession 0001558370-25-007276.Report this figure113Cash and equivalents, Q2 FY2025, at 2025-06-30$112.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-11, accession 0001558370-25-010975.Report this figure113Cash and equivalents, Q3 FY2025, at 2025-09-30$112.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-10, accession 0001104659-25-108847.Report this figure45.5Cash and equivalents, FY2025, at 2025-12-31$45.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-12, accession 0001104659-26-094902.Report this figure62.1Cash and equivalents, Q1 FY2026, at 2026-03-31$62.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-11, accession 0001104659-26-058650.Report this figure155Cash and equivalents, Q2 FY2026, at 2026-06-30$154.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-12, accession 0001104659-26-094902.Report this figure
Current assets$mnot reported160Current assets, period not labelled, at 2023-12-31$160.0m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-03, accession 0001558370-25-001999.Report this figure327Current assets, Q1 FY2024, at 2024-03-31$327.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-08, accession 0001558370-24-007197.Report this figure309Current assets, Q2 FY2024, at 2024-06-30$308.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-14, accession 0001558370-24-012236.Report this figure292Current assets, Q3 FY2024, at 2024-09-30$292.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-14, accession 0001558370-24-015624.Report this figure227Current assets, FY2024, at 2024-12-31$227.0m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-05, accession 0001104659-26-024127.Report this figure186Current assets, Q1 FY2025, at 2025-03-31$185.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-12, accession 0001558370-25-007276.Report this figure250Current assets, Q2 FY2025, at 2025-06-30$250.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-11, accession 0001558370-25-010975.Report this figure321Current assets, Q3 FY2025, at 2025-09-30$321.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-10, accession 0001104659-25-108847.Report this figure333Current assets, FY2025, at 2025-12-31$332.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-12, accession 0001104659-26-094902.Report this figure349Current assets, Q1 FY2026, at 2026-03-31$348.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-11, accession 0001104659-26-058650.Report this figure394Current assets, Q2 FY2026, at 2026-06-30$394.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-12, accession 0001104659-26-094902.Report this figure
Total assets$mnot reported163Total assets, period not labelled, at 2023-12-31$163.1m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-03, accession 0001558370-25-001999.Report this figure328Total assets, Q1 FY2024, at 2024-03-31$327.8m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-08, accession 0001558370-24-007197.Report this figure309Total assets, Q2 FY2024, at 2024-06-30$308.9m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-14, accession 0001558370-24-012236.Report this figure293Total assets, Q3 FY2024, at 2024-09-30$292.7m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-14, accession 0001558370-24-015624.Report this figure275Total assets, FY2024, at 2024-12-31$274.9m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-05, accession 0001104659-26-024127.Report this figure215Total assets, Q1 FY2025, at 2025-03-31$215.5m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-12, accession 0001558370-25-007276.Report this figure270Total assets, Q2 FY2025, at 2025-06-30$269.5m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-11, accession 0001558370-25-010975.Report this figure327Total assets, Q3 FY2025, at 2025-09-30$326.6m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-10, accession 0001104659-25-108847.Report this figure333Total assets, FY2025, at 2025-12-31$333.2m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-12, accession 0001104659-26-094902.Report this figure349Total assets, Q1 FY2026, at 2026-03-31$349.3m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-11, accession 0001104659-26-058650.Report this figure395Total assets, Q2 FY2026, at 2026-06-30$394.7m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-12, accession 0001104659-26-094902.Report this figure
Current liabilities$mnot reported11.6Current liabilities, period not labelled, at 2023-12-31$11.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-03, accession 0001558370-25-001999.Report this figure10.0Current liabilities, Q1 FY2024, at 2024-03-31$10.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-08, accession 0001558370-24-007197.Report this figure12.1Current liabilities, Q2 FY2024, at 2024-06-30$12.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-14, accession 0001558370-24-012236.Report this figure15.2Current liabilities, Q3 FY2024, at 2024-09-30$15.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-14, accession 0001558370-24-015624.Report this figure17.3Current liabilities, FY2024, at 2024-12-31$17.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-05, accession 0001104659-26-024127.Report this figure13.0Current liabilities, Q1 FY2025, at 2025-03-31$13.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-12, accession 0001558370-25-007276.Report this figure19.6Current liabilities, Q2 FY2025, at 2025-06-30$19.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-11, accession 0001558370-25-010975.Report this figure21.6Current liabilities, Q3 FY2025, at 2025-09-30$21.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-10, accession 0001104659-25-108847.Report this figure25.9Current liabilities, FY2025, at 2025-12-31$25.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-12, accession 0001104659-26-094902.Report this figure25.0Current liabilities, Q1 FY2026, at 2026-03-31$25.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-11, accession 0001104659-26-058650.Report this figure27.8Current liabilities, Q2 FY2026, at 2026-06-30$27.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-12, accession 0001104659-26-094902.Report this figure
Total liabilities$mnot reported11.8Total liabilities, period not labelled, at 2023-12-31$11.8m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-03, accession 0001558370-25-001999.Report this figure10.1Total liabilities, Q1 FY2024, at 2024-03-31$10.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-08, accession 0001558370-24-007197.Report this figure12.2Total liabilities, Q2 FY2024, at 2024-06-30$12.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-14, accession 0001558370-24-012236.Report this figure15.2Total liabilities, Q3 FY2024, at 2024-09-30$15.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-14, accession 0001558370-24-015624.Report this figure17.3Total liabilities, FY2024, at 2024-12-31$17.3m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-05, accession 0001104659-26-024127.Report this figure13.0Total liabilities, Q1 FY2025, at 2025-03-31$13.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-12, accession 0001558370-25-007276.Report this figure19.6Total liabilities, Q2 FY2025, at 2025-06-30$19.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-11, accession 0001558370-25-010975.Report this figure21.6Total liabilities, Q3 FY2025, at 2025-09-30$21.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-10, accession 0001104659-25-108847.Report this figure25.9Total liabilities, FY2025, at 2025-12-31$25.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-12, accession 0001104659-26-094902.Report this figure25.3Total liabilities, Q1 FY2026, at 2026-03-31$25.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-11, accession 0001104659-26-058650.Report this figure27.9Total liabilities, Q2 FY2026, at 2026-06-30$27.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-12, accession 0001104659-26-094902.Report this figure
Shareholders' equity$m(133)Shareholders' equity, period not labelled, at 2023-09-30−$132.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-14, accession 0001558370-24-015624.Report this figure(153)Shareholders' equity, period not labelled, at 2023-12-31−$153.2m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-05, accession 0001104659-26-024127.Report this figure318Shareholders' equity, Q1 FY2024, at 2024-03-31$317.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-10, accession 0001104659-25-108847.Report this figure297Shareholders' equity, Q2 FY2024, at 2024-06-30$296.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-10, accession 0001104659-25-108847.Report this figure277Shareholders' equity, Q3 FY2024, at 2024-09-30$277.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-10, accession 0001104659-25-108847.Report this figure258Shareholders' equity, FY2024, at 2024-12-31$257.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001104659-26-094902.Report this figure203Shareholders' equity, Q1 FY2025, at 2025-03-31$202.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001104659-26-094902.Report this figure250Shareholders' equity, Q2 FY2025, at 2025-06-30$249.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001104659-26-094902.Report this figure305Shareholders' equity, Q3 FY2025, at 2025-09-30$305.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-10, accession 0001104659-25-108847.Report this figure307Shareholders' equity, FY2025, at 2025-12-31$307.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001104659-26-094902.Report this figure324Shareholders' equity, Q1 FY2026, at 2026-03-31$324.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001104659-26-094902.Report this figure367Shareholders' equity, Q2 FY2026, at 2026-06-30$366.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001104659-26-094902.Report this figure

Cash flow

Operating cash flow−$39.6m, Q2 FY2026
Line itemUnitperiod not labelled2023-09-30period not labelled2023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(15.4)Operating cash flow, period not labelled, three months to 2023-09-30−$15.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-14, accession 0001558370-24-015624. Derived: 9-month figure less the 6-month figure.Report this figure(14.9)Operating cash flow, period not labelled, three months to 2023-12-31−$14.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-03, accession 0001558370-25-001999. Derived: 12-month figure less the 9-month figure.Report this figure(18.6)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$18.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-12, accession 0001558370-25-007276.Report this figure(19.1)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$19.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-11, accession 0001558370-25-010975. Derived: 6-month figure less the 3-month figure.Report this figure(16.3)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$16.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-10, accession 0001104659-25-108847. Derived: 9-month figure less the 6-month figure.Report this figure(16.2)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$16.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-05, accession 0001104659-26-024127. Derived: 12-month figure less the 9-month figure.Report this figure(68.0)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$68.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-11, accession 0001104659-26-058650.Report this figure(26.1)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$26.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-12, accession 0001104659-26-094902. Derived: 6-month figure less the 3-month figure.Report this figure(35.8)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$35.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-10, accession 0001104659-25-108847. Derived: 9-month figure less the 6-month figure.Report this figure(30.7)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$30.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-05, accession 0001104659-26-024127. Derived: 12-month figure less the 9-month figure.Report this figure(41.9)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$41.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-11, accession 0001104659-26-058650.Report this figure(39.6)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$39.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-12, accession 0001104659-26-094902. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)47.61m, Q2 FY2026
Line itemUnitperiod not labelled2023-03-31period not labelled2023-06-30period not labelled2023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares1.3Diluted shares (weighted), period not labelled, three months to 2023-03-311,287,574 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-08, accession 0001558370-24-007197.Report this figure2.0Diluted shares (weighted), period not labelled, three months to 2023-06-301,999,705 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-14, accession 0001558370-24-012236.Report this figure2.6Diluted shares (weighted), period not labelled, three months to 2023-09-302,607,192 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-14, accession 0001558370-24-015624.Report this figure25.0Diluted shares (weighted), Q1 FY2024, three months to 2024-03-3125,046,531 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-12, accession 0001558370-25-007276.Report this figure33.5Diluted shares (weighted), Q2 FY2024, three months to 2024-06-3033,502,347 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-11, accession 0001558370-25-010975.Report this figure33.6Diluted shares (weighted), Q3 FY2024, three months to 2024-09-3033,581,810 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-10, accession 0001104659-25-108847.Report this figure33.9Diluted shares (weighted), Q1 FY2025, three months to 2025-03-3133,898,870 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-11, accession 0001104659-26-058650.Report this figure35.0Diluted shares (weighted), Q2 FY2025, three months to 2025-06-3035,006,114 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-12, accession 0001104659-26-094902.Report this figure41.9Diluted shares (weighted), Q3 FY2025, three months to 2025-09-3041,912,905 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-10, accession 0001104659-25-108847.Report this figure45.1Diluted shares (weighted), Q1 FY2026, three months to 2026-03-3145,067,658 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-11, accession 0001104659-26-058650.Report this figure47.6Diluted shares (weighted), Q2 FY2026, three months to 2026-06-3047,606,857 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-12, accession 0001104659-26-094902.Report this figure

Shares outstanding: 49.31mShares outstanding, period not labelled, at 2026-08-1049,307,729 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-12, accession 0001104659-26-094902.Report this figure at Aug 10, 2026, from the cover of the 10-Q filed Aug 12, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. Listed shows no prices and gives no investment advice.